R.H. Bluestein & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $822K | Buy |
6,125
+500
| +9% | +$67.1K | 0.05% | 104 |
|
|
2022
Q2 | $862K | Buy |
5,625
+350
| +7% | +$53.6K | 0.05% | 111 |
|
|
2022
Q1 | $855K | Hold |
5,275
| – | – | 0.04% | 120 |
|
|
2021
Q4 | $714K | Hold |
5,275
| – | – | 0.03% | 159 |
|
|
2021
Q3 | $569K | Hold |
5,275
| – | – | 0.02% | 200 |
|
|
2021
Q2 | $594K | Sell |
5,275
-500
| -9% | -$56.3K | 0.02% | 202 |
|
|
2021
Q1 | $625K | Sell |
5,775
-507
| -8% | -$54.9K | 0.03% | 173 |
|
|
2020
Q4 | $673K | Buy |
6,282
+2,507
| +66% | +$269K | 0.03% | 143 |
|
|
2020
Q3 | $331K | Sell |
3,775
-37
| -1% | -$3.24K | 0.02% | 230 |
|
|
2020
Q2 | $374K | Buy |
3,812
+658
| +21% | +$64.6K | 0.02% | 189 |
|
|
2020
Q1 | $240K | Buy |
3,154
+420
| +15% | +$32K | 0.02% | 223 |
|
|
2019
Q4 | $242K | Buy |
+2,734
| New | +$242K | 0.01% | 309 |
|
|
2019
Q3 | – | Sell |
-3,850
| Closed | -$280K | – | 329 |
|
|
2019
Q2 | $280K | Buy |
+3,850
| New | +$280K | 0.01% | 252 |
|
|
2018
Q4 | – | Sell |
-4,555
| Closed | -$431K | – | 285 |
|
|
2018
Q3 | $431K | Buy |
4,555
+700
| +18% | +$66.2K | 0.02% | 194 |
|
|
2018
Q2 | $357K | Buy |
3,855
+1,100
| +40% | +$102K | 0.02% | 205 |
|
|
2018
Q1 | $261K | Buy |
+2,755
| New | +$261K | 0.01% | 272 |
|
|
2015
Q1 | – | Sell |
-3,550
| Closed | -$232K | – | 341 |
|
|
2014
Q4 | $232K | Buy |
+3,550
| New | +$232K | 0.01% | 315 |
|